3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Lymphoma, Large B-Cell, Diffuse
80
Leukemia, Myeloid, Acute
74
Multiple Myeloma
70
Breast Neoplasms
70
Lymphoma, Non-Hodgkin
62
Lymphoma
61
Leukemia, Lymphocytic, Chronic, B-Cell
53
Burkitt Lymphoma
52
Recurrence
51
Myelodysplastic Syndromes
50
Lymphoma, Follicular
50
Lymphoma, B-Cell
47
Leukemia
43
Triple Negative Breast Neoplasms
40
Lymphoma, Mantle-Cell
38
Neoplasms
37
Hodgkin Disease
34
Melanoma
33
Lymphoma, B-Cell, Marginal Zone
32
Hematologic Neoplasms
31
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
29
Neuroblastoma
28
Ovarian Neoplasms
26
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
22
Neoplasm Metastasis
22
Pancreatic Neoplasms
21
Leukemia, Biphenotypic, Acute
21
Sarcoma
18
Myeloproliferative Disorders
17
Interventions
Specimen Handling
9
Magnetic Resonance Spectroscopy
6
Biopsy
6
pembrolizumab
3
X-Rays
3
Nivolumab
3
olaparib
2
durvalumab
2
ceralasertib
2
Paclitaxel
2
Immunoglobulin G
2
Carboplatin
2
trastuzumab deruxtecan
1
sargramostim
1
ribociclib
1
pelcitoclax
1
cobimetinib
1
cediranib
1
capivasertib
1
cabozantinib
1
atezolizumab
1
Tissue Banks
1
Taxes
1
TIC10 compound
1
Radiation
1
Phantoms, Imaging
1
Minimally Invasive Surgical Procedures
1
Ipilimumab
1
Indocyanine Green
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Cyclophosphamide
×
1 year
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled